ABSTRACT
SUMMARY OBJECTIVE: This study aims to analyze the risk factors for in-hospital mortality in a cohort of patients admitted to a newly adapted intensive care unit in a public hospital in Rio de Janeiro. METHODS: This was an observational, retrospective, and descriptive study. Data were obtained from electronic medical records. Coronavirus disease 2019 (COVID-19) was diagnosed by detecting viral ribonucleic acid using reverse transcription polymerase chain reaction. Factors associated with the risk/protection from death were determined using the odds ratio and adjusted odds ratio. RESULTS: Fifty-one patients were admitted to the hospital. The median age of the patients was 63 years, 60% were male patients, and 54% were white patients. Sixty-seven percent of the patients were diagnosed with COVID-19. Sepsis at admission increased the chance of in-hospital death by 21 times (adjusted odds ratio=21.06 [0.79-555.2]; p=0.06). The strongest risk factor for death was the development of septic shock during hospitalization (adjusted odds ratio=98.56 [2.75-352.5]; p=0.01), and one in four patients had multidrug-resistant bacteria. Mechanical ventilation, vasopressors, neuromuscular blockers, and sedatives were also the risk factors for in-hospital mortality. The in-hospital mortality rate was 41%, and the mortality rate of patients on mechanical ventilation was 60%. The diagnosis of COVID-19 was not statistically related to the adverse outcomes. CONCLUSIONS: In this cohort, the strongest risk factor for in-hospital death was the development of nosocomial septic shock. Healthcare-associated infections have a significant impact on mortality rates. Therefore, to have a better outcome, it is important to consider not only the availability of beds but also the way healthcare is delivered.
Subject(s)
Humans , Male , Cross Infection , COVID-19 , Brazil/epidemiology , Retrospective Studies , Risk Factors , Cohort Studies , Hospital Mortality , Delivery of Health Care , SARS-CoV-2 , Hospitalization , Hospitals, Public , Intensive Care Units , Middle AgedABSTRACT
A doença pulmonar obstrutiva crônica (DPOC) é uma patologia de grande prevalência na sociedade contemporânea, causando grande morbimortalidade e consumo de recursos em saúde. Apesar de flagrante melhora no entendimento de sua fisiopatologia e acréscimo no arsenal terapêutico experimentado nas últimas duas décadas, ainda existe grande parcela de doentes que convivem com limitação funcional extrema a despeito de tratamento clínico otimizado, reabilitação cardiopulmonar e oxigenoterapia suplementar. Tratam-se dos pacientes com doença em estágio avançado, que até pouco tempo só tinham como alternativa terapêutica o transplante pulmonar ou cardiopulmonar. Porém, nos últimos dez anos, esse panorama sombrio vem ganhando mais uma alternativa viável e factível, mesmo em pacientes com comorbidades limitantes e em países como o nosso, onde a realização de transplante pulmonar em larga escala não é uma realidade. Trata-se do tratamento endoscópico do enfisema pulmonar. Dentre as modalidades de terapia disponíveis atualmente, discutiremos o uso de válvulas endobrônquicas, método dos mais estudados, já com diversas publicações importantes e recentemente incluído no documento GOLD como opção terapêutica nos pacientes com doença pulmonar obstrutiva crônica.
Chronic obstructive pulmonary disease is a highly prevalent pathology in contemporary society, causing great morbidity, mortality and consumption of health resources. Despite a striking improvement in the understanding of its pathophysiology and increase in the therapeutic arsenal experienced in the last two decades, there is still a large number of patients living with extreme functional limitation despite optimal clinical treatment, cardiopulmonary rehabilitation and supplemental oxygen therapy. They are those patients with advanced disease that until recently had only as a therapeutic alternative the lung or cardiopulmonary transplantation. However, in the last ten years, this bleak picture has been gaining yet another viable and feasible alternative, even in patients with limiting comorbidities and in countries such as ours, where large-scale lung transplantation is not a reality. It is the endoscopic treatment of pulmonary emphysema. Among the modalities of therapy currently available, we will discuss the use of endobronchial valves, a method most studied, already with several important publications and recently included in the GOLD document as a therapeutic possibility in patients with chronic obstructive pulmonary disease.
Subject(s)
Humans , Male , Female , Pulmonary Emphysema/therapy , Bronchoscopy , Pulmonary Disease, Chronic Obstructive/therapy , DyspneaABSTRACT
Os corretos diagnósticos e estadiamento do câncer de pulmão são verdadeiros desafios na prática clínica diária do pneumologista e do cirurgião de tórax. O surgimento de técnicas endoscópicas minimamente invasivas como o ultrassom endobrônquico (EBUS) e a técnica de aspiração transbrônquica por agulha fina guiada por ultrassom endobrônquico (EBUS-TBNA) vem mudando significativamente a abordagem da neoplasia pulmonar. Desde sua descrição na literatura médica há cerca de uma década, inúmeros trabalhos, incluindo ensaios clínicos controlados, revisões sistemáticas e metanálises têm demonstrado a importância do método. A propagação da técnica de EBUS-TBNA pelo mundo e sua incorporação por serviços de referência em pneumologia no Rio de Janeiro e no Brasil torna importante uma revisão atual das características técnicas do procedimento e dados relevantes da literatura sobre o tema.
The correct diagnosis and staging of lung cancer are real challenges in the daily clinical practice of the pulmonologist and the chest surgeon. The emergence of minimally invasive endoscopic techniques such as endobronchial ultrasound (EBUS) and the endobronchial ultrasound-guided transbronchial needle aspiration technique (EBUS-TBNA) have significantly changed the approach of pulmonary neoplasia. Since its description in the medical literature about a decade ago, countless studies, including controlled clinical trials, systematic reviews and meta-analyzes have demonstrated the importance of the method. The spread of the EBUS-TBNA technique throughout the world and its incorporation by pneumology referral services in Rio de Janeiro and Brazil makes it important to have a current review of the technical characteristics of the procedure and relevant literature data on the subject.
Subject(s)
Humans , Male , Female , Endoscopic Ultrasound-Guided Fine Needle Aspiration , Lung Neoplasms/diagnosis , Neoplasm Staging , UltrasonographyABSTRACT
A amiloidose é doença caracterizada por depósitos extracelulares de proteínas amilóides. Mais frequentemente, sua apresentação ocorre de forma sistêmica, porém essa enfermidade também pode manifestar-se de forma localizada, em determinado órgão ou sistema. Neste trabalho, os autores relatam dois casos da forma pulmonar, com manifestações clínico-radiológicas distintas.
The amyloidosis is a disease characterized by extracellular deposits of amyloid proteins. More frequently the presentation takes place in a systemic way, however this illness also can happen in a located form in a determined organ or system. In this work, the authors report two cases of the pulmonary form with different clinical and radiographically patterns.
Subject(s)
Humans , Male , Adult , Middle Aged , Amyloidosis , Metabolic Diseases , Lung/pathology , Tomography, X-Ray ComputedABSTRACT
As vasculites são sempre casos que desafiam e fascinam, até mesmo os clínicos mais experientes, por suas apresentações nem sempre evidentes, desde o início da investigação diagnóstica. Os autores relatam um caso de início tardio de asma grave, associado à doença de vias aéreas altas, eosinofilia persistente, nódulos pulmonares, neuropatia periférica e hematúria com dismorfismo eritrocitário. Uma análise dos dados obtidos durante a investigação levou ao diagnóstico de Síndrome de Churg-Strauss.
Subject(s)
Humans , Male , Middle Aged , Asthma/diagnosis , Eosinophilia , Churg-Strauss Syndrome/diagnosis , Vasculitis , Diagnostic Techniques and Procedures , Signs and SymptomsABSTRACT
Inicialmente descrita em 1957, a associação entre silicose e esclerose sistêmica (síndrome de Erasmus) ocorre, possivelmente, por alterações humorais e celulares, desencadeadas pela toxicidade da sílica. Neste relato, os autores descrevem o caso de um homem de 41 anos, com síndrome de Erasmus, admitido com uma cavitação pulmonar infectada.